GenMont Biotech (Taiwan) Market Value
| 3164 Stock | TWD 20.05 0.10 0.50% |
| Symbol | GenMont |
GenMont Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GenMont Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GenMont Biotech.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in GenMont Biotech on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding GenMont Biotech or generate 0.0% return on investment in GenMont Biotech over 30 days. GenMont Biotech is related to or competes with CHC Healthcare, Sinphar Pharmaceutical, Abnova Taiwan, and Wellell. GenMont Biotech Incorporation engages in the research, development, and production of functional probiotics in Taiwan More
GenMont Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GenMont Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GenMont Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 4.87 | |||
| Value At Risk | (1.83) | |||
| Potential Upside | 1.32 |
GenMont Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GenMont Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GenMont Biotech's standard deviation. In reality, there are many statistical measures that can use GenMont Biotech historical prices to predict the future GenMont Biotech's volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | 4.07 |
GenMont Biotech Backtested Returns
GenMont Biotech holds Efficiency (Sharpe) Ratio of -0.3, which attests that the entity had a -0.3% return per unit of risk over the last 3 months. GenMont Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GenMont Biotech's Market Risk Adjusted Performance of 4.08, standard deviation of 0.9678, and Risk Adjusted Performance of (0.14) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.0457, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning GenMont Biotech are expected to decrease at a much lower rate. During the bear market, GenMont Biotech is likely to outperform the market. At this point, GenMont Biotech has a negative expected return of -0.26%. Please make sure to check out GenMont Biotech's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if GenMont Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.17 |
Very weak predictability
GenMont Biotech has very weak predictability. Overlapping area represents the amount of predictability between GenMont Biotech time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GenMont Biotech price movement. The serial correlation of 0.17 indicates that over 17.0% of current GenMont Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
GenMont Biotech lagged returns against current returns
Autocorrelation, which is GenMont Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GenMont Biotech's stock expected returns. We can calculate the autocorrelation of GenMont Biotech returns to help us make a trade decision. For example, suppose you find that GenMont Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GenMont Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GenMont Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GenMont Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GenMont Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
GenMont Biotech Lagged Returns
When evaluating GenMont Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GenMont Biotech stock have on its future price. GenMont Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GenMont Biotech autocorrelation shows the relationship between GenMont Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in GenMont Biotech.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for GenMont Stock Analysis
When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.